New Oregon Law Allows Early Market for Recreational Cannabis Edibles, Concentrates

Oregon Gov. Kate Brown signed a bill into law this week that will establish an early marketplace for the limited retail sale of recreational cannabis edibles and concentrates.

The law, Senate Bill 1511, also establishes a system wherein recreational dispensaries will be able to provide tax-free cannabis to medical marijuana patients.

Under the new changes, medical dispensaries will be allowed to sell a single low-dose edible and/or the equivalent of a small vape pen filled with cannabis concentrate to adults who are 21 and older.

It remains unclear exactly when Oregon’s real recreational market will come online, but officials have stated that it should launch before the end of 2016.

Last year, the Oregon legislature voted to allow medical marijuana dispensaries to sell cannabis flower and plant clones to recreational consumers who are 21 or older. It was a widely supported move among the cannabis industry, and simply recognizing how public opinion toward marijuana has shifted earned Oregon lawmakers a great deal of respect. Until now, however, consumers did not have access to Oregon’s long-established medibles and cannabis concentrate markets.

End


Mary’s Medicinals Sues RX Green Over Alleged Conspiracy

Mary’s Medicinals, one of Colorado’s flagship cannabis companies, announced a lawsuit on Wednesday against a competing company’s founding partner.

The lawsuit names Joshua Meacham — a founding partner at RX Green Cannabis — in accusations of harassment, slander, libel, civil conspiracy and a string of other shady business practices, including the intentional interference with prospective business and contractual relations. Specifically, the suit accuses Meacham of using a series of online aliases to file complaints against Mary’s Medicinals, both through the company’s customer service branch, the Colorado Marijuana Enforcement, and with other cannabis companies as well. Investigators were ultimately able to link several such complaints back to an IP address registered to Meacham.

“To me, the most despicable part of all of this is that someone would pose as a patient who truly needed help just to try to harm our business,” said Nicole Smith, CEO and founder of Mary’s Medicinals. “These actions undermine the heart and soul of our industry, and everything we are working so hard to accomplish to further patient rights and their access to clean, consistent cannabis therapeutics. This pettiness harms all of us.”

Neither Meacham nor a representative from RX Green responded to inquiries about the subject.

Editor’s Update 4/2/2016: RX Green has since published a press release acknowledging the suit and announcing that they “plan to aggressively defend ourselves against these claims.”

End


Joy Beckerman: The Future Hemp Economy

Joy Beckerman is the founder of Hemp Ace, in addition to being a nationally-recognized industrial hemp activist and expert. As a hemp consultant, she is a frequently-sought speaker at industry events, and was a panelist in the Economic Benefits of Cannabis and Hemp panel that we attended at this year’s Washington Cannabis Summit. Joy recently joined our podcast host Shango Los for a discussion of the far-reaching impact that industrial hemp is likely to have on our economy, ranging from food agriculture, to textiles, to fuel, and even nanotechnology. She also outlines how the industry will likely formulate and grow as hemp cultivation is legalized across the country, and how outdoor hemp farming can coexist with outdoor cannabis crops.

Listen to the podcast below, or scroll down for the full transcript!

Subscribe to the Ganjapreneur podcast on iTunes, Stitcher, SoundCloud or Google Play.


Listen to the podcast


Read the transcript

Shango Los: Hi there and welcome to the Ganjapreneur.com Podcast, I am your host Shango Los. The Ganjapreneur.com Podcast gives us an opportunity to speak directly to entrepreneurs, cannabis growers, product developers, and cannabis medicine researchers all focused on making the most of cannabis normalization. As your host I do my best to bring you original cannabis industry ideas that will ignite your own entrepreneurial spark and give you actionable information to improve your business strategy, and improve your health, and the health of cannabis patients everywhere. Today my guest is Joy Beckerman. Joy Beckerman is president of Hemp Ace International, an industrial help consulting and brokerage firm serving domestic and international clients. She is the industrial hemp advisor to the North West Farmers Union, and sits on multiple advisory panels and boards. She owned the first hemp store in New York in the early 1990’s and was appointed to serve as the secretary of the Vermont Hemp Counsel in 1996.

Joy then also developed an extensive career as a compliance and complex civil litigation paralegal working with some of Seattle’s most distinguished attorneys. Joy is the recipient of the national hemp industries associations 2014 hemp activist of the year award, and works extensively with policy makers. She is an internationally renowned public speaker and conducts continuing legal education seminars for attorney’s on industrial hemp related law and policy. Thanks for being on the show Joy.

Joy Beckerman: Such an honor and a pleasure Shango.

Shango Los: Joy, often episodes about hemp focus on the astounding array of products that can be made from hemp. Today’s show is going to be a little different, focusing more on the business opportunities that exist within hemp today. That said it would be important to understand the wide array of the industries that American hemp agriculture can impact, so let’s start there. Would you give us a snapshot of the variety of industries that are going to be impacted when hemp comes online here in the U.S?

Joy Beckerman: My favorite story to tell, the full spectrum. We start with the seed because that’s where the least amount of infrastructure needs for us to take advantage of that market. We buy ninety percent of the seeds from Canada, so seed is for nutritional, cosmeceutical, and industrial purposes. Not just fuel because there are other parts and I’m sure we’ll talk about them further on about fuel from the actual cellulose, but also varnishes and protectants. From there we move onto paper, tech styles, twine, yard, cordage, building materials, bio composites, and now and this we didn’t see coming twenty-five years ago, nano technology and super capacitors. It is endless.

Shango Los: I’ve got to hit on the nano tech, in what way does hemp expand to nano tech?

Joy Beckerman: Thank you, well right now what we have for the best RND material and the greatest material that we could use on the market are carbon nano tubes. What we’re talking about, surface area in strength on a nano level, which is about I think to the nine millionth exponential factor, something very, very small. For example, if you wave your hand in front of your face right now a nano meter is about how much your fingernail grew as you waved your hand in front of your face. What they have discovered is that hemp cellulose is the most valuable bio-cellulose on the planet, and it is second in surface area and strength only to carbon nano tubes. In terms of super capacitors we are finding that it is superior to graphene. They’re even starting to make biomedical nano technology, sort of fake skins and everything. I mean we are really making huge strides, and that was about in August of 2014 is when that research started to be released publicly.

Shango Los: I’m really glad that you mentioned that, you know I really mostly think about the plastics, the fibers, the clothes, and the ropes but the high tech impacts are going to be huge as well. Before we can achieve that bright future with hemp we’ve got to make hemp a national industry, and that’s dependent on the laws changing. Give us a road map, what is the legal status of hemp agriculture right now and where are the hot spots of where it seems to be growing in our country?

Joy Beckerman: Thank you for asking that, well you know I have to say that the feds have the hemp heroes in the federal legislature, which is very bipartisan. They have carved out a path for a truly responsible way for us to reintroduce industrial hemp state by state. That happened in the agricultural act of 2014, which most folks refer to as the farm bill. There was an amendment that was included that changed history, and changed the landscape for cannabis. That is section 7606, which is known as the legitimacy of industrial hemp research. Very simple, plainly written two page bill, double spaced and in that bill some very important things happened. One is industrial hemp was defined and distinguished from marijuana for the first time in U.S. history, and it is defined as any part of the plant cannabis sativa whether growing or not that contains greater than .3% THC on a dry weight basis.

Where as our definition of marijuana in the controlled substances act does not discuss this earnest, small, non scientifically based … God help him, he regrets very much having being responsible for this .3, but so where as the definition of marijuana doesn’t include this .3 now we have a definition for industrial hemp which does. A side note, and we’re going to bring that up I’m sure later on with regard to the market for cannabinoid extraction, non euphoric cannabinoid extraction from the plant material, and flowers essentially of the hemp plant. It does not have in this definition of industrial hemp a carve out for the resins, which those of us who have, you know, deeply studied the law and policy from the marijuana tax act through the controlled substances act with regard to that definition of marijuana. We know that even in that second sentence of the definition which details the exception for the oil, seed, and fiber variety of cannabis of course industrial hemp, there’s still an exclusion to the exception in that sentence and that is for the resins of the hemp.

Where as in this definition of industrial hemp, in the farm bill, section 7606 there is no carve out. That becomes very significant as we begin to talk about what Kentucky, and Colorado, and Oregon are doing and the hemp truck that they are driving through this gray area, this hole.

Shango Los: Are those going to be the states that we’d consider our hot spots right now would be Kentucky and Colorado? They are on the vanguard of all of this?

Joy Beckerman: Yes, and with Oregon close behind. What I also want to say is that Section 7606 was very clear, you are only states that, “Permit the cultivation of hemp.” That doesn’t say legalize, that says that permit the cultivation of hemp through the state legislative process will be allowed to take advantage of this. On top of it once the state legislature permits it, permits the growth of it they generally in these bills also say that their state departments of agriculture will now form rules. In section 7606 only, state departments of agriculture and institutions of higher education are allowed to do these agricultural pilot programs. Now that is another term that’s defined in there, “Agricultural Pilot Program.” In that we are allowed to study the cultivation, the growth, and the marketing of industrial hemp.

Now that word marketing included in this research amendment is huge because we are considering that also a big hole to drive a hemp truck through, and we’re calling that commerce. We’re saying that’s a green light, and guess what? The feds are also saying that’s a green light. There are a couple of really important other pieces of federal legislation for me to discuss, but I sense you might have a question before I move onto those.

Shango Los: Yeah you’re right about that. What I’m seeing is that at the federal level they’ve given us the green light. Now the ball is in the states; courts, and Kentucky, and Colorado, and Oregon are quick to jump. I’m assuming there are a couple of other states who are coming up behind, I actually am aware of the recent disappointing veto in Washington. There’s a bipartisan legislation that had made it through both the house and the senate and got to Governor Inslee’s desk and he vetoed it, kind of in revenge from what I hear for the house and the senate not passing the budget that he’s looking for. I’m already hearing whispers that this bill is going to be reintroduced and they’re going to massage that.

For everybody who’s aware of that and concerned about what happened, what’s the latest update on the Washington legislation?

Joy Beckerman: Well what’s happening in Washington is very interesting because we’ll be the twenty eighth state to permit the cultivation of hemp once we get that bill passed, and I’ll touch upon that in a second. To answer your first question we have twenty seven technically states that have legalized hemp, only eight that have ever put seeds in the ground because of this oversimplification of what hemp cultivation is. Bills and policy are not written that will actually allow seeds to go in the ground. Having said that for sure Kentucky, Oregon, and Colorado are in the forefront. Washington, we’ve been at it now for three years, working on these hemp bills. This year the WSDA and I decided basically we were going to get together, get a united front, and double team the legislators because we’ve had competing bills each year both in party and in house. That has in itself been a problem within the legislature.

This year we, with some of the new laws that have passed, particularly section 763 of the Consolidated Appropriations Act, which we’ll talk about in a little bit, we knew for Washington that we were going to make our bill in-compliant with section 7606 because now we have a lot of additional protections. Having said that we will, right now as the governor you say has indeed punished the legislature for not doing the one thing that the governor believes the legislature should have done this year. He punished them by taking thirty seven of the bills that they basically worked hardest to agree on the most, and twenty seven of them he vetoed which we do believe is the largest batch that was ever vetoed in the Washington state legislature, ten he didn’t because they had to do with health and safety.

Lucky for us it is the senate majority leader who needs to reopen that vote, and it is the senate majority leader, Senate Mark Schoesler who is a cosponsor of the senate bill for industrial hemp. We believe that he’s going to reintroduce that.

Shango Los: That’s certainly really convenient right? So often when something gets vetoed you have to go back to square one and try to convince someone to reintroduce it but the fact that it’s actually the sponsor really makes your job that much easier. You know, we need to take a short break for a moment Joy. We’ll be right back, you are listening to the Ganjapreneur.com Podcast.

Welcome back, you are listening to the Ganjapreneur.com Podcast, I’m your host Shango Los. Our guest this week is Joy Beckerman, president of Hemp Ace International. Joy right before the break you had mentioned a recent federal bill that included additional protections and how those were going to move us forward so quickly. Will you go ahead and break that out?

Joy Beckerman: Thank you, so each year our federal government even though they haven’t passed a balance budget in fourteen years, they do pass a consolidated appropriations budget because things do have to move forward annually. This year we had some additional protections, I’m sure we can thank the state of Kentucky which has moved forward with true high CBD low THC varieties of cannabis that fit a legal definition of industrial hemp but are being grown specifically for non euphoric cannabinoids. Of course the property mostly being targeted as you can imagine is cannabidiol CBD, so they really had to protect themselves. They knew they could take advantage of the fact that this new industrial hemp definition did not include resins, but meanwhile they do know that the resins are still included in the controlled substances act as a scheduled one control substance.

In this consolidated appropriations act of 2016, buried within section 763 it says, “The department of justice and the drug enforcement administration may not use funds to one, in contravention of section 7606 of the agricultural act of 2014.” By the way that language existed in this bill from last year, so that’s not new, we had that language last year that it said in contravention of section 7606. That wasn’t very clear, was it? They added language that was adopted and became the law of the land on December 18 of 15, and it now also says, “Or two, to prohibit the cultivation, transportation, processing, or sell of industrial hemp that is cultivated in compliance with section subsection 7606 of the AG act of 2014,” and get this, “Within or outside of the state in which it is grown.”

It is only because I know I’m on radio that I’m not yelling and crescendoing my voice as I say that because this is huge you guys, this is historical that we are now, the feds are heroes, our federal legislative hemp heroes have now created this research pathway, which by the way is responsible because we don’t have cultivars here in America that will serve immediate needs. We have to reach outside of our borders to get pedigrade seed from the thirty one developed countries that have these beautiful varieties that are meeting sophisticated demands of today’s global markets for these many industries that I just discussed. We have got to be able to access those seeds. As we access them and plant them in these research crops, some of them are failing and what we don’t want is large growth commercial farming right out of the gate for hemp where we have crops that fail. The naysayers will say, “Oh, they said hemp was going to save the world, they said hemp would grow everywhere,” which it doesn’t by the way, not without irrigation and other inputs.

The point is we’ve got to have success, so the fact that we get to reintroduce under research really helps us learn and not have this horrible judgement when as we learn and crops may fail along the way, as we test cultivars. Having said that this new language that protects the transportation, and the processing, and the sale beyond state lines is more of a giant hole for Kentucky, for Colorado, for Oregon, and hopefully for Washington. I’m going to give you a bit of the, I don’t want to say bad news but obstacle that we’re facing in Washington even when we pass our bill with regard to this cannabinoid extraction market. The reality that even in Canada where they have legalized since 1998 they are mostly growing only for seed. Shango, that’s because it’s expensive to create an infrastructure to process that long, tall, strong, hard fiber, the stock.

In Canada, again, since 1998 for the most part they actually plow their fiber back into the ground. Matter of fact …

Shango Los: Wow.

Joy Beckerman: Yes, we buy ninety percent of their seeds. What we have to do as we look at the business opportunities that are immediately open to us, and then that we can grow into are one, the seed nutrition. We have combines, most states already have seed crushing facilities and meal facilities. By that I mean we take the meal that the seed cake, that’s left over from pressing any seed generally and that is dried and then sifted and ground into various powders, that’s where we get hemp protein powder from. It’s not ground up seeds, that would make a nut butter. It’s the ground up and milled seed cake left over from the seed industry. Anyway, we have those infrastructures in most states. The only thing we’re missing in most states are dehulling mechanics, that is the dehulling takes the shell of the hemp seed and separates it from that beautiful nutrient-dense, protein-filled heart. Of course it is the highest form of protein, and the highest digestible form of protein, and the highest essential fatty acid profile in the entire planet animal kingdom. That’s your immediate market.

Second immediate market, and this is why these protections in the consolidated appropriations act of 2016 are so significant are non euphoric cannabinoid extraction. To the extent that industrial hemp can be ethically grown for human consumption, and for a therapeutic and medical market. There are high standards and ethics that go along with that, of course you would understand, that we then can just use extraction technology which is not nearly as expensive as the infrastructure to decorticate the fiber. Right now the Kentucky department of agriculture is valuing that crop at ten thousand dollars an acre. I work very closely with the Washington state department of agriculture and of course I have brought the Kentucky department of agriculture into our meetings so that we can educate our own state on the incredible opportunities that Kentucky is taking advantage of and they are taking advantage of non euphoric cannabinoids.

When they say ten thousand dollars an acre I’m saying even if they’re wrong by ten times let’s go a thousand dollars an acre, it’s eighty dollars an acre for hay, and about …

Shango Los: Yeah that’s still an incredible return.

Joy Beckerman: It’s huge, and it would generate the revenue that we need to build the infrastructure for these decorticating facilities and processing facilities for the stock, which is where we’re going to be getting our paper, textiles, twine, yarn, building materials, our bio composites, nano technology, and super capacitors. Brother, that is all going to come from the stock but we have to build the infrastructure. I do want to say, because this is very important to the entrepreneurs out there, that it isn’t just the old school decorticating facilities which separate the bast fiber, which is the bark, or the long fibrous outside of the stem from that inner woody core which we call the shid, or the herd. A basic decorticating facility is going to separate that bast from the herd, but what we seen in modern day is then they take it that much further. Then they’re processing the herd to different geometric particle sizes to serve different purposes, whether it’s a bio aggregate for say hemp cream building material, or whether it be used for animal bedding, or a ply wood made with hemp type thing.

Having said that, this is very important for the entrepreneurs out there. There is a technology that has been patented by a company called, “Pure Vision Technology” based out of Fort Lepton Colorado, this is Dr. Winger and the Lurburger brothers, Ed Lurbuger. They have a patented technology that’s fractionalization, it separates the stock into cellulose, linens, and sugars. From those three elements we can make thousands of industrial products and it applies to many applications including methane fuel. Now they have created a secondary company called, “Pure Hemp Technology LLC,” this is the licensing arm that licenses the Pure Vision Fractionalization technology and they even have a new testing facility going up in Southern Oregon. I’ll wrap this up for you, but to tell you what we ultimately need to see around this great country are processing facilities within fifty miles of every biomass feed stock, whether they’re the fractionalization, decortication, or dehulling, and seed pressing, and seed cake milling. Those are the main mechanics that we want to see.

Then of course we need to go into textiles, which China is way ahead of us. Right now there are only three paper companies in American that could process hemp fiber. All of those infrastructures need to be built, but we’re talking about immediately seeds and non euphoric cannabinoids.

Shango Los: Well that’s a pretty great picture and a timeline that we’ve built there. First we’ve got the feds giving the green light, then we’ve got the rules being made at the state level, then we’re moving into seed nutrition, a non euphoric CBD which is going to cause the capital to exist in the industry to start building these decorticators fifty miles from where the farms are. There’s a lot of opportunity for money to be made and for this to all happen very swiftly it sounds like. We need to take another short break, we’ll be right back, you are listening to the Ganjapreneur.com Podcast.

Welcome back, you are listening to the Ganjapreneur.com Podcast, I’m your host Shango Los. Our guest this week is Joy Beckerman, president of Hemp Ace International.

So far on the show we have had a whirlwind timeline of what’s going on in hemp right now from the federal government giving the green light, the states making it’s rules, and now all of the capitalists getting to their particular roles to make this all happen and raise the money to start building these decorticators. At the same time the medical cannabis and recreational cannabis industries also on the rise in our country, and you know Joy one of the things that I hear most is a spastic concern of people that industrial hemp is going to come online outdoors and cross pollinate into the recreational and medical cannabis outdoor crops. You know we’re big fans on this show of outdoor growing of marijuana because of the decreased carbon footprint from indoors, but everybody’s got an opinion about whether or not there’s going to be cross pollination or not.

I figure you have probably got some fact, so boil that down for us. Are we going to see an issue with industrial hemp cross pollinating into recreational cannabis?

Joy Beckerman: Thank you for asking this really important question which I can only preface by saying it is a shared concern. You must know of course that we will easily convert our industrial hemp farmers into interstate and international drug farmers if God forbid their hemp should creep up over .3% THC. It is just as much of a concern of marijuana cross pollinating with the industrial hemp as it is in the reverse. I just always want to preface by saying that. The reality is that it is distance only that I see the state of Washington using in terms of a barrier between cross pollination. Ultimately we know that bees travel about three miles from their hive, and even though it’s true and this is where the hysteria comes from … well there are two pieces actually. It’s true that there have been studies out there that say, “Pollen can travel two thousand miles from one continent to another and we have proof of that.” It’s a small planet, this little blue marble that we all share together so that’s now how we deal with agriculture.

It’s actually a fairly common concern with very common solutions. Those solutions would be A, distance. B, not planting at the same time as many fields, corn, and sweet corn folks do. As a matter of fact there’s a licensed hemp farmer in Oregon who is also a corn farmer and he has a neighbor who plants corn, and his neighbor plants GMO corn and he plants non GMO corn, so they don’t plant at the same time. Having said that for industrial hemp, AOSCA, which is the Association of Official Seed Certifying Agencies, for the first … and this is the seed certifying agency that most developed countries subscribe to, China does not which is why we don’t normally get human consumption items from China. They have developed as Canada has, a way to keep even cultivars, because there are hundreds of cultivars and varieties of industrial hemp, from cross pollinating by distance. With just different types of industrial hemp it can go from one foot, to three miles to avoid cross pollination.

If I’m a betting woman I would say that the WSDA is simply going to use the distance of a maximum of three miles keeping in mind that it just does so happen that our own seed certification gentlemen from our WSDA is also just so happens to sit on that international sub committee for AOSCA, so it has been particularly sophisticated in learning about industrial hemp from the last couple of years due to his position on that international sub committee. That has been very beneficial to us. Now, do we want to absolutely respect our outdoor growers? I want you to know, I am the first line of defense in our own state legislature in Washington. I want you to know by the way, just a side note, that in Washington in our current bill once it has passed, we’re not going to be allowed to collect plant material for non cannabinoid extraction.

I realize I digress a little bit, but before the show ends I do want everyone to know that has been written out of our bill, we’re only going to be allowed to use seeds and not plant material. We will not be taken advantage of that great financial opportunity, and there are reasons for that, that perhaps I’ll go to in another show. It has to do with testing standards, WSDA’s testing standards versus our liquor and cannabis board, and the WSDA standards are much higher.

In any event, moving back to cross pollination. I’m the first line of defense because there are legislatures that are in these agricultural parts of our state that are so pro-hemp that they want to pass a law to make all of the marijuana go indoors. I sit there and say, “Oh you know not what you say, please. That would be an environmental catastrophe.” Number one, we cannot have all of our marijuana go indoors and we need to continue to increase the canopy, I think, of our legal marijuana market. While I am definitely a proponent of using distance I also recognize that there are parts of our state where there are particular amount of sun grown marijuana. It is potential that in those parts of our states, perhaps we should make those regional and put barriers around those and say, “You know what? We’re not going to allow hemp farming in these particular regions.”

An interesting thing, in Oregon the Oregon hemp industries association has put a voluntary moratorium. I don’t think that I would be able to do that in Washington, I am an industry leader here and a trade association leader here but I don’t like going up against farmers. Legislators in that manner are telling hemp farmers that what I think they should do versus what the department of agriculture is telling them to do. Having said that I will probably take on the same tact of discouraging large scale commercial hemp farming around certain areas of the state, to the extent that it’s not law.

Shango Los: Distilling it down the short answer is yes, there’s going to be cross pollination. There’s going to be cross pollination from hemp to peoples personal grows, there’s going to be cross pollination from gorilla grows over to hemp, there’s going to be cross pollination between hemp and legal grows that it’s going to have to be worked out either by when they are each planted, or distance. On a botany level this is going to be a real problem.

Joy Beckerman: I have to correct you, no, I have to correct you. It’s absolutely not going to be a real problem. Everything that you said, as much as I love you, has actually just contributed to the hysteria. I did a bad job explaining.

As much as we want to …

Shango Los: In under twenty seconds do you think you can clean that up?

Joy Beckerman: Yes, and we’re going to start out with those distances so that we can collect hard data to disprove the hysteria that exists. Pollen from industrial hemp is large, it would take tremendous climactic and wind factors in order for it to travel any significant distance at all. We want to start out by making everybody feel comfortable, we are going to learn to thrive and prosper together. Cousins, and sisters, and brothers in cannabis and we want to start out by making everybody comfortable with these distances and collect the hard data so that we can disprove the hysteria and close up those distance gaps. That’s what I’m saying.

Shango Los: Right on, well thank you for re-clarifying that because I definitely didn’t get the right gist. That’s all the time we have for today, thanks for being on the show Joy.

Joy Beckerman: It’s such an honor and a pleasure, thank you Shango for everything you do for cannabis everyday.

Shango Los: You can connect with Joy Beckerman at HempAce.com. You can find more episodes of the Ganjapreneur podcast in the podcast section at Ganjapreneur.com, and in the apple iTunes store. On the Ganjapreneur.com website you will find the latest cannabis news, product reviews, and cannabis jobs updated daily along with transcriptions of this podcast. You can also download the Ganjapreneur app in iTunes and Google Play. You can now also find the show on the I Heart Radio network app, bringing Ganjapreneur to sixty million mobile devices. Do you have a company that wants to reach our national audience of cannabis enthusiasts? Email grow@ganjapreneur.com to find out how.

Thanks to Brasco for producing our show, I’m your host Shango Los.

End


Obama Commutes Prison Sentences of 61 Drug Offenders

President Obama commuted the sentences of 61 drug offenders on Wednesday, continuing his widely-publicized effort to reform the United States’ broken federal justice system.

According to White House counsel Neil Eggleston, more than one third of the prisoners whose sentences were commuted today had been serving life sentences. Furthermore, the majority of these prisoners will be released as early as July 28.

According to the White House, President Obama has now commuted more prison sentences than the past six presidents combined. With a total of 248 inmates’ sentences commuted during his two terms, however, he remains very far off from his stated goal of shortening 10,000 prison sentences before leaving office.

Earlier this week, the president turned a page on drug law enforcement, publicly acknowledging that it’s time to treat opioid and heroin abuse as national health crises, not criminal ones. As part of that action, the president issued rule changes allowing doctors to provide more helpful care to individuals suffering from opiate addictions.

“Expanding access to medication-assisted treatment for opioid-use disorders has been a top priority for this administration,” said Michael Botticelli, director of the White House Office of National Drug Policy. “Research clearly shows that this approach, when combined with behavioral therapies, is more effective at sustaining recovery and preventing overdose.”

While the Obama administration appears to have only barely warmed to the idea of drug policy reform, these are good signs that the president will continue to work toward fairer treatments for U.S. citizens caught up in the federal justice system due to illegal drugs. And hopefully — if Obama doesn’t step up soon — our next president will be more willing to take drastic actions toward ending the international drug war once and for all.

End


Whoopi Goldberg Launches New MMJ Brand Featuring Products for Menstrual Cramps

Whoopi Goldberg has teamed up with established marijuana edibles maker Maya Elisabeth to launch a California-based MMJ company — called Whoopi and Maya — which will sell medicinal cannabis products designed to help relieve women from the discomfort of menstrual cramps.

Goldberg, co-host of The View, has long been known as a passionate supporter of medical cannabis and marijuana political reform efforts, though this will be her first foray into the business itself.

Elisabeth is owner of the female-run marijuana edibles company Om Edibles, which is based out of San Francisco and is known for products that combine cannabis with superfoods.

Whoopi and Maya’s product line will consist of cannabis edibles, topicals, tinctures, and a THC-infused bath soak. The company will also offer CBD-rich options for individuals who wish to avoid the psychoactive effects of cannabis but still want the relief.

“For me, I feel like if you don’t want to get high high, this is a product specifically just to get rid of discomfort,” she says. “Smoking a joint is fine, but most people can’t smoke a joint and go to work,” Goldberg said in an interview with Vanity Fair.

Whoopi and Maya products will only be available to medical marijuana patients in California.

End


Etain’s Fourth and Final Dispensary Opens Friday in Yonkers, NY

Etain is opening its fourth dispensary in Westchester County, New York on Friday, the last location afforded to the company under the Compassionate Care Act.

The dispensary will be the first in Yonkers.

Yonkers Mayor Mike Spano will join the Peckham family, joint owners of Etain, in a ceremonial ribbon cutting today. Spano wholly supported having a dispensary in the city during his State of the City address earlier this month.

“In Yonkers, we recognize the need for patients who suffer from debilitating illnesses to live with less pain and with dignity,” Spano said in a press release. “We welcome Etain to our community to provide a medically-proven service that often times is the only form of relief for critically ill patients.”

Vireo Health also has a location in Westchester County. Their dispensary in White Plains opened in January but is only open on Fridays and Saturday, according to information provided by Google.

“It remains to be seen what economic impact this will deliver for Westchester County,” Phil Oliva, spokesman for County Executive Rob Estorino said when dispensary locations were announced. “But we do expect that the businesses will be good neighbors and that they will operate strictly within the confines of the law.”

Just five companies were allowed to open dispensaries in the state under the law, with each permitted one cultivation facility and four dispensaries. The regulations do not allow for plant matter to be consumed, instead opting for oil-based products, such as tincture sprays and capsules.

End


Colorado Proposals Would Cap THC Content In Cannabis Products

Both a ballot initiative and an amendment to a House bill in Colorado are aiming to put an upper limit on the potency of cannabis products sold in the state.

The proposed cap on THC content — 15 to 16 percent — is lower than what most products currently contain. The average THC content of cannabis flower in Colorado is 17.1 percent. Cannabis extracts contain on average 62.1 percent THC.

Backers of the proposed amendment, which was introduced by Republican Rep. Kathleen Conti, argue that the legislation is a necessary measure of caution until more research has been done regarding the effects of cannabis on the neural development of adolescents.

Opponents of the proposition claim that it goes too far, and could snuff out some of the industry’s most popular sectors.

According to Conti, “All the studies that have been done on THC levels have been done on THC levels between 2 and 8 percent. Most of the marijuana coming in now, the flowers are being rated at a THC count of about 17 percent on average, so this is dramatically over, and we really don’t know that we’ve gotten the true feel on the health risks associated with that marijuana.”

In contrast, cannabis industry compliance expert Mark Slaugh has stated that the proposed limit is “unconstitutional” and poorly-conceived: “I don’t think a lot of thought was put into the proposals. This bill threatens to wipe out most infused product manufacturers, and its language is unclear as to what to do with edibles.”

End


Pennsylvania Medical Marijuana Bill Facing Potential Roadblock in Senate

Pennsylvania’s medical marijuana bill has potentially been thrown into limbo as it returns to the Senate for approval before heading to Gov. Tom Wolf for a final signature, the Cental Penn Business Journal reports.

The bill originated more than year ago in the Pennsylvania Senate, but ultimately underwent serious changes during its time being discussed in the House of Representatives, and the bill now returning to the Senate is a completely different beast.

Senators are left with two choices: they can approve the legislation and send it to Gov. Wolf, who has promised to sign any MMJ law put before him, or they can make adjustments and send the bill back to the House for reconsideration.

The second option, advocates worry, could ultimately lead to the bill’s death. Though the law recently passed through the House with a vote of 149-43, it was an arduous and hard-fought battle bringing the bill to a vote. If the Senate were to make additional changes, it could be another year before the House would be ready to cast its approval again.

Even if the Senate approves the law this session, a fully-functional Pennsylvania medical marijuana program would probably not exist until 2018.

End


Hawaii Lawmakers Pass Resolution to Determine Safe THC Levels While Driving  

Hawaii officials have introduced a resolution asking the state Health Department to conduct a study to determine how much marijuana a driver can safely consume before operating a motor vehicle, the Associated Press reports.

The resolution comes as the state begins setting up its revamped medical marijuana infrastructure.

“I think that it’s really important that we do this now,” Rep. Cindy Evans (D), one of 15 resolution signees, said. “Hopefully this is the beginning of the discussion.”

If conducted, the study could lead to laws specifying how much THC in the blood stream is acceptable while driving. Laws in Colorado, Montana and Washington set that limit at 5 nanograms per millimeter of blood, while in Nevada and Ohio the limit is 2 nanograms. Exemptions for medical marijuana patients are provided by some states.

The National Institute of Drug Abuse says marijuana is the illegal drug most often found in the blood of drivers in accidents, but it’s unclear how often it plays a role in those accidents because of how long marijuana remains in a person’s system. The National Highway and Traffic Safety Administration warns that marijuana impairs driving related skills and cognitive functions.

Virginia Pressler, director of the Health Department, said that the National Institute of Drug Abuse has not been able to establish a benchmark despite many years of reviewing the issue and, especially because the resolution doesn’t include funding, her department doesn’t have the capacity to undertake such a study.

The House Committee on Transportation passed the measure on Mar. 28. It moves to the Committee on Health.

End


Russian Government Attempts to Silence U.S.-Based Cannabis Educator

The Russian government has distanced itself from a growing trend of international cannabis normalization with a fruitless and comedic attempt at controlling the free speech rights of a U.S. citizen.

Medical cannabis entrepreneur and educator Jerry Whiting was warned this week by the Russian government to stop distributing information online related to the growing of cannabis.

“I was flattered that I … got their attention,” Whiting told Ganjapreneur in a phone interview about the incident.

Whiting, whose personal blog Jet City Orange was targeted by essentially a Russian cease and desist order, provided Ganjapreneur with the email he received from the Russian Federal Service for Supervision in the Sphere of Telecom, Information Technologies and Mass Communications (ROSKOMNADZOR). The Russain agency also cc’d Whiting’s website hosting service, who undoubtedly had a few confused head-scratching moments before moving on to actual complaints.

According to Whiting, Jet City Orange is “my personal website that I’ve had for years … it’s basically my personal soap box. Only a small portion of it concerns cannabis.”

Nonetheless, the email charges Whiting with the operation of “web­sites containing … information prohibited for public distribution in the Russian Federation,” with a direct link included to the medical cannabis sections of his blog. Ironically, these sections were not written, translated, or offered in any form in Russian — though Whiting says he now plans to get translations up as soon as possible to show ROSKOMNADZOR what he thinks of their figurative muscle-flexing.

“I’m talking about what I love and what I do. That’s why I was surprised that it garnered the attention outside of the U.S. … but it’s not like I have a lock or monopoly on teaching people how to grow pot,” Whiting said.

As for the letter itself: “You can bet I’m going to print it out and frame it.”

Jerry Whiting is also founder of Leblanc CNE, a company focused on the development of CBD-rich and heirloom medical cannabis strains.

You can read the letters below.

russianletter1 russianletter2

End


Nationwide Support for Legal Cannabis Reaches All-Time High, Poll Shows

According to an Associated Press-NORC Center for Public Affairs Research survey, 61 percent of Americans now believe marijuana should be legalized. The figure represents an all-time high, up from the 58 percent who supported legalization in a Gallup poll last October.

In the poll, 33 percent said cannabis should be legal “with no restrictions,” 43 percent said, if legalized, there should be “restrictions on purchase amounts,” while 24 percent said it should only be legal with a medical prescription.

“This is yet another demonstration of just how ready Americans are for the end of marijuana prohibition,” Tom Angell of the Marijuana Majority, a marijuana reform group, said in a Washington Post report. “The growing level of support for legalization that we see in poll after poll is exactly why we’re now in a situation – for the first time in history – where every major presidential candidate in both parties has pledged to let states set their own marijuana laws without federal interference.”

Full legalization was popular among 70 percent of Democrats, 65 percent of independents and 47 percent of Republican respondents.

Kevin Sabet of Smart Approaches to Marijuana, an anti-legalization lobby group, said that despite the overall majority the report “does not show strong support for legalization at all” due to the number of people surveyed that would see marijuana restricted to a medical prescription.

However this poll is just the latest indicating a positive trend for legalization support. At the start of the Obama administration less than half – 44 percent – of Americans supported legalizing the drug.

End


FDA Butting Heads With CBD Herbal Remedy Retailers: Time to Face Facts

Though THC — the cannabinoid most commonly associated with cannabis and which is largely responsible for the plant’s psychoactive effects — remains prohibited at the federal level, cannabidiol (CBD) has been gaining ground as a major medical breakthrough.

There is extensive anecdotal evidence showing that high-CBD, low-THC treatment results in relief from a wide range of ailments, including epileptic seizures and Parkinson’s to severe pain and migraines. There are also several animal studies from Europe starting to provide scientific evidence to support these results.

And, because the high-CBD, low-THC products are non-intoxicating, they are rapidly growing in popularity.

As a result, herbal remedies made from hemp-derived CBD have seen explosive growth, particularly among individuals who live in states where medical cannabis is still prohibited, but who wish to experience the widely-touted benefits of CBD. This is because, while pot-derived products cannot be legally distributed on a national level, there is a quasi-legal market for the processing and distribution of CBD-based products derived from cannabis’s non-psychoactive sister plant, hemp — which can be legally imported from a country where hemp cultivation is allowed.

Recently, the U.S. Food and Drug Administration (FDA) decided to crack down on some of the more established retailers of these CBD-based herbal remedies, which generally have been able to sell their products online to people from all 50 states.

Ganjapreneur has received a letter sent by the FDA to one such retailer, HealthyHempOil.com. In the letter, the FDA warns that the information presented on the Healthy Hemp Oil website and its social media pages misleads consumers into believing they are buying a tried and true medicinal product. The letter cites several specific violations for the website to address, noting that, “failure to promptly correct these violations may result in legal action without further notice, including, without limitation, seizure and injunction.”

Reports indicate that other companies have received similar warning letters.

Admittedly, we share similar concerns. The FDA’s actions — though easy to chalk up as an ongoing prohibitionist crusade against cannabis — appear to address legitimate concerns over the well-being and fiscal security of American consumers. And remember: this is the FDA, not the DEA, issuing threats. These are the regulators, not the policemen.

The truth is, the retailers of hemp-derived CBD products have been pushing these herbal remedies with research originally conducted on the CBD found in medical cannabis, which — although closely related to hemp — is simply not the same thing. The successful CBD trials to date have by and large been conducted using whole-plant therapy, where patients were using CBD in the presence of a low dose of THC in order to achieve the Entourage Effect, the ultimate source of healing.

Hemp-derived CBD remains an unknown in many senses, and products containing solely CBD may provide zero relief for most people. It is legally and morally irresponsible to present it as something other than that.

It’s not that we don’t support these products or the entrepreneurs behind them, but we believe that cutting corners in the national normalization process is ultimately not going to help the industry.

If you’d like to learn more about the Entourage Effect or the science behind hemp-derived CBD, check out the Ganjapreneur podcast episodes featuring renowned cannabis researcher Dr. Ethan Russo and researcher/entrepreneur Mike West, respectively.

End


Chile Begins Harvest of Latin America’s Largest Legal Cannabis Crop

Various medical cannabis organizations in Chile began harvesting Latin America’s largest single crop of legal cannabis on Wednesday.

The field, which is the most expansive on the continent, lies in rural southern Chile, not far from the Andes Mountains.

The harvesting project was given the go-ahead by the Chilean government, and will cut down the buds of some 6,000 cannabis plants for transformation into various phytopharmaceuticals for the country’s 4,000 medical cannabis patients.

All of this is being done for free. The purpose of the project is to provide cannabis for use in three clinical studies, which will be run by the Chilean National Cancer Institute and two hospitals.

Ana Maria Gazmuri, president of the Daya Foundation, said that “it is an important day. We want it to be the first harvest of many more to come in Latin American countries.” The Daya Foundation promotes alternative therapy research.

The clinical studies are being funded by 20 municipalities, and will focus on the effectiveness of cannabis in treating patients suffering from cancer, refractory epilepsy and chronic pain.

Chile legalized the production and sale of hemp-derived drugs last December. Puerto Rico and Colombia have recently followed suit.

Although marijuana remains on Chile’s list of hard drugs, Chilean president Michelle Bachelet signed an order at the end of 2015 that gave the Institute of Public Health the power to authorize the production of marijuana for medicinal purposes.

End


MMJ Tax in LA Could Fund Homeless Services Plan

Los Angeles, California city officials have proposed a 15 percent tax on medical marijuana sales and cultivation in the city in order to generate funds for homeless housing and services, according to a document outlining potential means.

If approved, the plan is estimated to raise $16.7 million annually based on current medical marijuana receipts, but that number could increase significantly if recreational marijuana were approved in the state and subjected to the same rate.

It is not unheard of for a municipality to levy additional taxes on top of the exiting 6 percent tax for medical marijuana gross receipts.  In 2014, Cathedral City and Desert Hot Springs, in Riverside County, each raised their tax to 15 percent and 10 percent, respectively. Santa Cruz city and county added a 4 percent retail tax and Shasta Lake City, in Shasta County, added a 6 percent sales tax.

Taxing medical cannabis is one of nine recommendations put forth by Chief Legislative Analyst Sharon Tso and City Administrative Officer Miguel Santana in the letter to members of the Homelessness and Poverty Committee.

Other options include a fee in lieu of inclusionary zoning, housing linkage fees, a real estate document fee, a bond worth up to $1.8 billion, a documentary transfer tax, a billboard tax, raising the sales and use tax 1 percent, and a parcel tax.

“There are multiple, anticipated initiatives involving marijuana on the Nov. 2016 ballot,” the authors noted as potential disadvantages for the plan “This may lead to confusion on behalf of the voting public.”

Whichever funding option is chosen by the committee will appear on the November ballot and would need to be approved by voters.

End


Oregon Health Authority Updates Concentrate Policies for Betterment of Patients

The Oregon Health Authority (OHA), facing backlash from the state’s medical marijuana community over a recent ban on the sale and production of cannabis concentrates, displayed a more progressive understanding of the crisis now facing patients situation in new rules rolled out this week.

The OHA’s recent ban on concentrates was intended only as a temporary condition — specifically, the agency banned the sale of concentrates that were produced by an unlicensed entity, which, because there are currently no licenses available, functioned as a blanket ban on that entire aspect of the industry.

The new rules, however, make some much-needed clarifications about the legality of extracts in Oregon.

Specifically, concentrates and edibles that are currently in circulation will be allowed to stay there. Furthermore, processors who have submitted a completed application by to the OHA can begin operating on April 1 under a provisional license. The rights to a provisional license will be removed October 1, 2016, after enough producers and processors have been officially licensed.

Read the full bulletin posted by the OHA below:

ohabulletin2

End


Cannabis Product Recalls and Other Rule Changes Announced in Washington

The Washington State Liquor and Cannabis Board (LCB) announced rule revisions yesterday that change many aspects of the Washington cannabis industry, including new product recall procedures for several different scenarios.

Hilary Bricken of the Canna Law Blog notes that under the LCB’s new rules, there will be three possible scenarios that could result in a product recall: exempt market withdrawals, in which licensees would recall a product over aesthetic or packaging issues; licensee-initiated recalls, wherein licensed producers and processors are expected to voluntarily withdraw products that contain contaminants or restricted pesticides; and board investigation-initiated recalls, which would only occur whenever a licensee “fails to engage in re­call efforts that meet the urgency of the risk to public health and safety.”

The LCB also removed language from the state’s marijuana rules that served as a total destruction stipulation for producers and processors whose products fail initial testing. Now, Board-issued penalties for producers and processors are purely monetary. This is particularly beneficial for Washington’s outdoor cannabis growers, who have been haunted since the market’s launch by the fact that a single failed test could result in the mandated destruction of their entire plot.

Here are a few other rule changes that the LCB identified in an email issued yesterday:

  • Revised the definition of “licensed premises” to include all areas of a premises where the licensee has leasehold rights and any vehicle assigned to transport marijuana;

  • Removed the requirement that “Mr. Yuk” stickers must be on all labels for marijuana infused edible solid and liquid products. The Board will work with the Washington State Poison Center to create a new indicator for marijuana infused products;

  • Added language that failure to address monetary penalties for two or more violation notices in a three year period will result in license cancellation. Licensees failing to respond to a violation or have outstanding fines shall not be eligible to renew;

End


Boston MMJ Advocacy Group Complaint Leads to City Council Process Changes   

Boston medical marijuana advocates say the City Council broke state open meeting laws by failing to provide the public 48-hour notice before a vote that ultimately approved buffer zone regulations for dispensaries, according to a Boston Globe report.

The Massachusetts Patient Advocacy Alliance accused the council of violating the law, prompting the city’s Law Department to send a letter to the state attorney general’s office acknowledging the “mistake.”    

In the letter, Adam Cedarbaum, on behalf of Law Department, said a typographical error was responsible for the wrong item being copied onto the agenda. City Council agendas will now be inspected by a proofreader to reduce future mistakes.

The city clerk caught the error and corrected the online version about 90 minutes after the agenda was posted, the letter said.

In their complaint, the patient group asked that the council take another vote on the plan and allow the customary public comment period. Instead, the Law Department proposed the group be given “ample notice of any opportunity to provide comment before any city commission or agency takes a binding vote or recommendation on the matter.”

The group will consult its advisory board before taking additional steps, Nichole Snow, executive director of the alliance said.

The measure would require dispensaries to be at least a half a mile apart. It would have to be approved by the Boston Redevelopment Authority and the Zoning Commission, and signed by Mayor Martin J. Walsh (D), to take effect.       

End


Global Leaders Will Discuss World Drug Problem & International Reform This 4/20

A ground-breaking 4/20 may be ahead of us as the United Nations General Assembly prepares for a special session to address global substance abuse issues. This will be the first time in almost 20 years that the UN will seriously review global drug policies, of which marijuana will be a major discussion point.

The United Nations General Assembly Special Session (UNGASS) will take place in New York from April 19 to April 21, and will be attended by numerous world leaders and heads of state to discuss global substance abuse and drug trafficking issues as well as three international drug control treaties that have notoriously stood in the way of global marijuana reform.

Though the underlying theme of the assembly will be to support the rights of individual countries to determine their own drug policies, the assistant secretary for the Bureau of International Narcotics and Law Enforcement Affairs, William Brownfield suggested that the Obama administration may actively push for drug policy reform instead of simply tolerating it.   

According to statements made by Brownfield during a press conference earlier this month,

“We will call for pragmatic and concrete criminal justice reform, areas such as alternatives to incarceration or drug courts, or sentencing reform. In other words, as President Obama has said many times publicly, to decriminalize much of the basic behavior in drug consumption in order to focus scarce law enforcement resources on the greater challenge of the large transnational criminal organizations.”

The three-day event will involve plenary meetings featuring statements by many high-ranking authorities including the President of the General Assembly, the Chair of the Commission on Narcotic Drugs, the Director-General of the World Health Organization and the President of the International Narcotics Control Board.

The conference will also include the participation of numerous high-level ministerial heads, medical experts, youth advocacy representatives, and members of the scientific and academic communities. Each participant will represent the best interests of their demographic in five, multi-stakeholder roundtable discussions. All participants will be encouraged to engage in the discussion, but will be limited to three to five minutes to present their stance so as not to interfere with the interactive nature of the event. Each roundtable will consist of five panelists and two co-chairs, each of which must be nominated to participate.

Numerous side events will occur simultaneously with the event, each outlining specific details about current global drug policies and their impact on society. They will look at statistics, trends and research pertaining to drug policies in terms of public health, sustainability and the effectiveness of current drug policy models.

Participation in side events is limited to representatives of non-government organizations who are actively working on drug related matters including the scientific and academic communities, civil society and youth group representatives. Anyone wishing to attend the UNGASS or any of its side events must register online before March 28, 2016.

The plenary meetings and interactive roundtables will be webcast live beginning at 10:00 am EST on Tuesday, April 19, 2016.

End


Portland Harborside Health Center

Recently, the Ganjapreneur team got to tour the newest Harborside Health Center cannabis dispensary, located in Portland, OR.

The original Harborside opened in 2006 in Oakland, California and has played a significant role in establishing standards for dispensaries and consultative care. The Oakland location was the first in the nation to support education for seniors, veterans and families with severely ill children; first in the country to offer CBD-rich medicine; and the first to treat children with Dravet syndrome. The dispensaries, led by cannabis thought leader and activist Steve DeAngelo, raise the bar for quality cannabis medicine and customer service in every city they open in.

harborside2

The dispensary in Portland is cheerfully painted, welcoming and has plenty of free parking. The waiting room is warm and the greeting staff are quick to smile and ask how they can be of service. A second door leads to the dispensary itself which is immediately invigorating.

harborside4

So often dispensaries are dreary affairs that feel claustrophobic and instill a feeling of distrust. Not so at Harborside. The high ceiling, elegant lighting and soothing furniture caused us to stop a moment to just soak it all in. This is clearly a destination dispensary built to make the statement that their meds are reliable and well-considered.

harborside3

As your eyes scan the room, their array of clones pop out bright green under fluorescent lights, giving the whole room a pleasant glow. One of the coolest aspects of this dispensary is the long glass topped table displaying all of the flowers that are no longer in stock.

harborside6

Not only is it simply delightful to view all of the strains gone by, but it is visually arresting to become aware of the sheer variety of medicine that has come through these doors. Always bringing in the best medical growers have to offer and the recent coolest strains too, the display case reminds you why Harborside is a world leader.

harborside8

The case showing what was available on the day we visited was packed with excellent expressions of some of our favorite strains and many that we were not familiar with. The nice, tight and colorful nugs looked like they had fallen out of a magazine even though it was simply their daily stock.

harborside7

Everything was lab tested as well to ensure potency for accurate dosing. The budtender on duty was exceptionally knowledgeable in both botany and health care and provided excellent feedback for us. They also carried an array of edibles, tinctures and concentrates in really well-designed packages, increasing confidence in the products.

harborside5

The dispensary manager Chris Helton came over to say hello and answer questions — what a sweetheart. Chris’s calm and warm demeanor made everyone feel welcome. He even put our conversation on hold to walk over and make sure newly arriving patients and customers were feeling welcome and served as well. Chris let us know about their positive relationship with the neighboring community and the free community pea patch out behind the dispensary. He has worked hard to make sure that Harborside would be a good neighbor to the existing shops who were a bit concerned about having a dispensary in the neighborhood. Now, everything has come together and the locals see the new dispensary as a welcome addition.

We have become fans of the Portland Harborside cannabis dispensary and look forward to our return visit soon. If you would like to learn more about founder Steve DeAngelo’s vision for compassionate care, you can listen to Steve’s appearance on the Ganjapreneur podcast.

Visit the Harborside Health Center:

5816 NE Portland Hwy
Portland, OR 97218
11am-9pm daily
(503) 912-4372
http://www.harborsidehealthcenter.com/Portland/

End


Nixon Official Admits Drug War Was a Hoax

A 1994 quote from a former Nixon aide makes it crystal clear that the administration’s reason for criminalizing drug use was purely to throw into disarray Black communities and the anti-war movement.

John Ehrlichman was serving as President Nixon’s chief domestic policy advisor when Nixon announced the roll-out of the War on Drugs. In seeking a massive expansion of federal drug agencies, the Nixon administration cited the pernicious impacts of drugs on social welfare.

The drug war has had ruinous economic and social consequences for the United States, Mexico, and Latin American countries, consequences which are especially pronounced for racial minorities.

Reporter Dan Baum spoke with Ehrlichman in 1994 while doing research for a book on drug prohibition. Ehrlichman, who served 18 months in prison for his involvement in the Watergate scandal, was frank about the Nixon administration’s motives in inaugurating the drug war. Baum writes in Harper’s cover story this April:

‘You want to know what this was really all about?’ he asked with the bluntness of a man who, after public disgrace and a stretch in federal prison, had little left to protect. ‘The Nixon campaign in 1968, and the Nixon White House after that, had two enemies: the antiwar left and Black people. You understand what I’m saying? We knew we couldn’t make it illegal to be either against the war or Black, but by getting the public to associate the hippies with marijuana and Blacks with heroin, and then criminalizing both heavily, we could disrupt those communities. We could arrest their leaders, raid their homes, break up their meetings, and vilify them night after night on the evening news. Did we know we were lying about the drugs? Of course we did.’

Criminalizing drug use had nothing to do with ensuring social welfare. The racist and paranoid Nixon administration wanted desperately to dismantle two populations: the Black community and the anti-war movement. The easiest way to do so was to criminalize behaviors common to them both.

Baum didn’t include this quote in his 1996 book, Smoke and Mirrors: The War on Drugs and the Politics of Failure, which contains no authorial interviews, but he did put it in the Harper’s cover story, “Legalize It All,” which puts forward a case for drug legalization.

The fact that the drug war was fabricated with malicious intent might not surprise everyone. We hope, though, that the news will sway prohibitionists to adopt a more rational stance.

End


New Jersey Panel Considers Expanding List of MMJ Qualifying Conditions

The health commissioner of New Jersey has put in place a panel that will decide whether various ailments should be included in the list of qualifying conditions for medical cannabis in the state, Philly.com reports.

Patients and advocates have been working for nearly four years to get more ailments added to the list of conditions, arguing that the list is severely restrictive and penalizes sick citizens who have no other viable recourse to obtain effective treatment.

Currently, the list of qualifying conditions for medical cannabis in New Jersey includes multiple sclerosis, epilepsy, HIV, AIDS, cancer associated with severe or chronic pain, glaucoma, Crohn’s disease, and terminal illnesses. Patients can purchase up to two ounces of cannabis each month with a recommendation from a qualified physician.

Patient advocates hope to see chronic pain, post-traumatic stress disorder, and other conditions added to that list.

Governor Chris Christie has repeatedly stated that he is opposed to any legislation that would expand the medical cannabis program, which he fears is a ploy to move toward legalizing recreational marijuana.

Ken Wolski, who heads the Coalition for Medical Marijuana New Jersey, said that although he is glad the panel has been formed, he doesn’t expect much to come of it, noting that the panel members lack the requisite expertise in medical cannabis.

Only one of the five doctors on the panel, Cheryl A. Kennedy, is among those who recommend medical cannabis to patients. Only 450 doctors in New Jersey currently participate in the medical cannabis program.

End


Colin Bell: From Academic to Entrepreneur

Colin Bell, PhD. is the co-founder, co-inventor, and chief growth officer of Growcentia, a manufacturer of organic soil supplements designed to minimize environmental impact. In his previous career as a research scientist at Colorado State University, Colin focused on understanding plant microbial interactions and produced many peer-reviewed publications on microbial mediated processes to enhance plant growth. With Growcentia, he has taken his scientific knowledge and applied it to business, solving real problems faced by farmers who want to grow better crops via sustainable methods.

Colin recently joined our host Shango Los for a conversation about the transition from academic to entrepreneur, how he manages work/life balance, how he fosters teamwork and camaraderie among coworkers in a start-up environment, and more.

Listen to the episode using the media player below, or scroll down for the full transcript!

Subscribe to the Ganjapreneur podcast on iTunes, Stitcher, SoundCloud or Google Play.


 

Listen to the podcast:


 

Read the full transcript:

Shango Los: Hi there and welcome to the Ganjapreneur.com podcast. I am your host Shango Los. The Ganjapreneur.com podcast gives us an opportunity to speak directly to entrepreneurs, cannabis growers, product developers, and cannabis medicine researchers all focused on making the most of cannabis normalization. As your host, I do my best to bring you original cannabis industry ideas that will ignite your own entrepreneurial spark, and give you actionable information to improve your business strategy and improve your health and the health of cannabis patients everywhere.

Today my guest is Colin Bell. PhD, co-founder, co-inventor, and chief growth officer for Growcentia. Colin received his PhD in 2009 in soil microbial ecology. His academic research was focused on understanding plant microbial interactions, and soil microbial biogeochemical cycling. As a research scientist at Colorado State University, his many peer reviewed publications were centered on elucidating microbial mediated processes that enhance plant growth.

Colin left his academic position at CSU in March of 2015 to launch his startup company Growcentia. Their first product, MAMMOTH P, is a beneficial bacteria bloom stimulant that targets phosphorus cycling to maximize both quality and yield in cannabis plants. Today we’re going to talk about making a leap from academic to entrepreneur. Thanks for being on the show, Colin.

Colin Bell: Thanks Shango, how’s it going?

Shango Los: It’s going really great. I’m excited to have you on the show because a lot of people are doing one thing, and they really in their heart wish they were doing something else, specifically being an entrepreneur. I’m excited to talk about the travel that you’ve taken, so that maybe it inspires some others. Let’s get started by really cementing you in the academic world. What were you doing at CSU, and kind of steep us in that a little bit.

Colin Bell: Great. I’ll start, like you said, I received my PhD in soil microbial ecology in 2009 after doing a couple post docs with on the USDA and the Forest Service in Fort Collins, Colorado. I achieved my third post doc at Colorado State University working with my team Matt Wallenstein and Rich Conant, who are also co-founders with Growcentia.

After a couple of years I got promoted to research scientist 1, where the whole time and my whole academic career and my graduate career also was focused on understanding plant microbe interactions, and understanding nutrient cycle. Like we said, to kind of understand how plants and microbes have evolved together and how microbes might benefit plants, in light of climate change or anything else, to help promote their growth and their success. We just did that. That was kind of my dream, to be an academic research scientist at the Natural Resource Ecology lab at Colorado State University. We were very successful there for years.

One day, kind of how it came about is, we decided that all the publications that our team had been pushing out, which was many, many, we questioned the impact we were making in academia. We always felt that our research would really help agriculture in general, and improve agriculture sustainability, and our technology ultimately, or our knowledge and our publications that we provide to the scientific community would translate to improved management practices for more sustainable, natural ways for plants to grow, to improve yield to feed the globe, the growing population, the world. Thinking that one day, out of all the papers and all the grants that we wrote. We have this broader impact statement that all the grants require.

We talk about how our research is going to impact agriculture and farmers and help farmers grow better. We kind of came to the realization that farmers probably weren’t reading our publications. As a matter of fact, it validated that. We decided that to be hiring a pack of scientists, we should start focusing more on applied problems to try and get our technology in the hands and in the forum that farmers could use in this lifetime. That’s when we switched the lab, flipped the lab, started thinking about problems, and thinking about applying our knowledge into making something that could be applied into agriculture practices. Reshape the labs, started thinking about it from the perspective of a soil microbial ecologist and what microbes do well, and how to produce that and scale that. You know what microbes do do well, is cycle nutrients and provide nutrients to plants among other things. That’s why plants and microbes have evolved together basically since the beginning of time.

Shango Los: Before we get too much into talking about the product itself, I want to talk about the lab a little bit. You’re talking about being within academia at that point. I’m sure that there’s a fine line between you are doing the research under the auspices of the school, but then there’s a certain point where suddenly you are actually becoming a business, which is, I don’t know, not usually the role of what the school is looking for. They’re often going for pure research. I could be wrong, maybe schools now are actually trying to roll out these products. How did you skirt that line between running your lab as a research lab versus coming up with the preparations to put a product onto the market.

Colin Bell: That’s a great question. Honestly, the truth is even a decade ago universities were focused on basic research. That’s kind of the structure. The infrastructure, truly, is still like that, but there’s a great push and a much improved emphasis on actually launching technology from the lab into the marketplace. I think it was helpful. Most universities now have tech transfer departments that focus specifically on helping researchers understand how to bridge that gap between the scientific lab and the marketplace.

I think there’s definitely a lot of work to do and a lot of progress to be made, but there has been a lot of progress made certainly in the last decade. How we did that really is working with our tech transfer department at Colorado State University and going through some rigorous incubators, business incubators. For example, the NSF I-Corps accepted us as a team. The NSF I-Corps program is a brilliant program developed by the national government, the NSF, to help researchers understand specifically how to identify the value of the technology that they’re developing potentially in the lab, and what it takes to launch that into a marketplace.

That was a rigorous training based on lean start-up methodologies of Steve Blank and some others, where we basically treated this exercise like an experiment. We had these hypothesis of value, and we had these hypothesis of customer segments. The way we validated that is we hypothesized there was particular value for whatever product. Our particular product was enhancing nutrient uptake to plants that ultimately enhance yield. We had that early stage, and we were very naive going into this, assuming that farmers would buy this type of product. The exercise is if you think you have a value and you think, you hypothesize, you have a customer segment, what you should do now is go talk to a hundred of those customer segment archetypes, farmers in this case, to validate if you’re right or not.

Shango Los: It sounds like you’re actually making almost your own focus group. You’re making your hypothesis, and I love hearing basic marketing repeated to me in lab speak. I’m enjoying this a lot. But also you would then go out and talk to your hundred subjects, and then you would be building up your own data base specific to your own product.

Colin Bell: That’s exactly right. What we’re trying to do is validate the value propositions that we think our product would bring to market. Through that process it was just invaluable, because we realized very quickly where we were wrong. We realized very quickly what the value was, with any particular agriculture market segment, that our product would need to meet to be a successful product to launch into the marketplace.

For example, if you talk to producers in the larger agro space, such as corn farmers and wheat farmers, et cetera, no matter what you think your product does to enhance the environment, et. We were kind of thinking about our product from an ecological standpoint also. It’s a natural microbial additive that improves nutrient use, but also it would allow us to potentially minimize inputs, which are sometimes caustic to the environment, such as excessive fertilizer, etc. We didn’t emphasize yield as a value proposition early on in our discovery. What we realized is that was the only thing almost that mattered to be able to successfully launch our product into the marketplace. That was the key value proposition for most agriculture market segments.

Shango Los: I would think that that is actually probably one of the reasons that you’ve had so much success early on. We’ll talk more about the success of the product in a minute. But specifically the fact that many entrepreneurs will come up with the idea, they’ll be passionate about it, and then they’ll go to the market with what their hunch is, but because you came at it as an academic scientist you’re like, “Well, I wouldn’t go to the market before I test my hypothesis,” and so you created your own study by going out and talking to these hundred farmers, which gave you all this new focus group information which becomes your new evidence. I would think that if most entrepreneurs would do that in their own way, we’d see a lot less failing companies.

Colin Bell: That’s exactly right. It’s called the lean start-up approach, and that’s exactly what I think you should do. I think you nailed it. Most startups fail because they haven’t rigorously validated the value and/or the customer segments that need that value, what we look for as pain points. What can that customer not live without? If your product can fill that pain point, you know you definitely have a successful product, but you have to validate it.

Shango Los: Thanks Colin. We’re going to take a short break and be right back. You are listening to the Ganjapreneur.com podcast.

Welcome back, you are listening to the Ganjapreneur.com podcast. I’m your host Shango Los, and our guest this week is Colin Bell of Growcentia. Colin, before the break we were talking about your background in academia and how deeply you were involved as a research scientist, and how the research that you were doing was going to help farmers, but you weren’t sure how the farmers were going to find out about it. You shifted your research into going past just developing what the farmers could do, and figuring out how to get your research into the hands of farmers by way of a product possibly. That brings us to where we are now.

The first product that Growcentia has put out is the Mammoth P. Can you tell us what is unique about this product that caused you in academia to go, “Wait a minute, this is something new and this could actually do good”?

Colin Bell: Sure. We are really excited about MAMMOTH P early on, and still. We are really excited that the technology because it’s so unique. The way we were thinking about developing a new microbial biostimulant product to enhance plant growth was just something that no other company, or any other lab for that matter, has come up with. What we wanted to do was target functionality at the microbial community level.

We wanted to work with microbial communities because we know in nature microbial species just don’t persist. They have to persist and function as a community. What we also want to do was train functionality for specific nutrient cycling. That way, we thought over time we could actually prescribe different microbial inoculants to treat certain deficiencies of nutrients, such as phosphorus or nitrogen. Our first product, MAMMOTH P, is a microbial community that specifically targets phosphorus, which means it liberates phosphorus as it’s bound in soylent substrates, which happens naturally almost immediately once phosphorus is added into soil, potting mix. It even chemically transforms into plant unavailable forms in hydroponic systems. We were able to train, using our proprietary microbial trait selection platform, to train microbial communities to increase their ability to cycle phosphorus by up to 30 times greater than any natural communities that we’ve found in nature.

Shango Los: To put it in my own terms, what it sounds like is phosphorus is going to be naturally occurring in the soil, but there are challenges for uptake for the plant. What you have done is you’ve put together a community of specially chosen microbes that when you introduce them to the soil, they do the job of unhinging the phosphorus from wherever they’re tied down, to become more bioavailable for your plant so your plant is able to thrive with more phosphorus, because it’s so much easier for it to get it out of the buffet in the soil. Is that a good way to put it?

Colin Bell: Yeah, I think that’s very well said. Nice job there. That’s exactly what it is. We find that the plants are able to take up a lot more phosphorus with our additive which enhances the plants ability to improve their bloom or yield, no matter what that plant might be. In the case of cannabis, it actually translocates phosphorus and micronutrients to higher levels than the plant could without our inoculum enhancing bloom growth and the density and the quality of the flower.

Shango Los: I have a feeling that your answer to this next question’s going to be over your head, but I’m dying to hear the answer anyway. I would love to hear you contrast how phosphorus is normally taken from the plant, what that process is like, compared to when you use your microbial communities. Kind of illustrates for us the difference, the value proposition, of why the microbial works so much better.

Colin Bell: In processing, now we identified this problem actually in natural agriculture soils, which is a prolific problem across the country. When farmers add phosphorus fertilizer to soils, up to 70% becomes almost immediately unavailable to plants because phosphorus binds, it’s chemically sticky, to minerals and carbon substrates alike. Phosphorus will immediately transform, once it hits a substrate, into plant unavailable forms. It’s a really unique and interesting ecological problem, because farmers really need, of all crops, really need plants that take up as much phosphorus as possible. Across all crops, phosphorus is in high demand, especially during the yield or flower cycles of the plant.

Over time, the phosphorus will continue to build up —let’s just talk about agro ecosystems right now — for up to two decades, where the exchange sites will keep on getting stuck with these phosphates, which is a plant available form of phosphorus, until over time the soil saturates and then flushes through the environment and creates huge ecological problems like algal blooms that we see quite often, polluting water ways, etc.

What this microbial community does is we’ve improved their capabilities to solubilize, which means exchange, those phosphorus molecules that were bound to the soil back into the solution in the plant available form phosphate PO4, which allows the plant to take up as much phosphorus as possible, mining those phosphates as they’re bound to soils and substrates alike. This happens even in hydroponic systems, and prolifically in cocoa, and peat, and soil systems as well.

Shango Los: Great. I followed that. I want to change gears for a second here. Now that we understand the importance of the product and why you were so excited to make the jump from academia to the entrepreneurial side, tell us a little bit about how you chose to then actually form the company. I’m holding a bottle of your product in my hand, and it is gorgeous. The design is great, the copywriting is great. Whoever laid out your branded colors. It’s an incredible, branded experience which you really don’t see all that much in the cannabis industry, or maybe we are just now starting to. You must have put some work into building the idea of the company around the product that you were feeling jazzed about.

Colin Bell: That’s right. I think what I have to emphasize for sure is nothing happens alone. We have a wonderful team helping us in every area of our business. Not only do I have wonderful and brilliant co-founders, but we hired a CEO that flew all the way from Chicago to be with us here in Fort Collins, Colorado, that’s grown many start-ups from the very beginning to multi-hundred million dollar companies. We have a great team on the ground, in all our packaging production. We talk about branding and marketing, we have consultants here, local in Fort Collins, Colorado, to help us with our social media. Another one Push IQ Chris Richardson, that helps us with our branding.

We also have a great list of external advisors, including the CEO of New Belgium and a former employee of theirs, Greg Owsley, which actually branded the New Belgium Fat Tire brand from their early days, which helped them be a very successful global company. Really, I didn’t do anything by myself. I surrounded myself and our ideas. We all want to be the dumbest person in the room. If we’re that, then we can really bring talent around the table to help us come up with these great ideas.

What we want to do for this is own our culture. We’re a scientific, highly technical company. The three co-founders including myself are PhD soil microbiologists. My other two co-founders are still faculty at Colorado State University. We wanted to be distinguished in every way we possibly could. We felt that clean brand, the white label with the mammoth, which is super iconic, really stood out and really kind of illustrated who we were as a company.

Shango Los: It is a good thing to surround ourselves with the people who are smarter than us when we’re building a company. The group that you have pulled together is pretty extraordinary though. I’m curious, were these people that were already in your network, because you are naturally a networker as an academic, or is it just that all of these people are smart enough to live in Fort Collins, Colorado, or is this something that people were attracted into your sphere of influence because of the incubator?

Colin Bell: I think a little bit of everything. We didn’t have these people in our lives before we started Growcentia, but what we do do is reach out to a lot of people. We present people with good opportunities. I think people see a good thing, the good thing that we’ve done with Growcentia, and that’s basically create a really interesting product in a very, very interesting market. We have some really compelling values. Not only do we have a wonderful product, but we have a wonderful platform that allows us to create a family of products.

Not only are we in this wonderful, very exciting market, which is projected to do just amazing things, we’re at the very base of something, that we think we can grow with the cannabis market as it grows. That’s very exciting. Our product is very well positioned to bring value into other markets too. That kind of started also with our investors M34. We were able, after three incubators, to bring on an early seed investment which allowed us to launch the company. That’s when I left the university, in March of 2015, to start the company.

Like I said, when you have a great story- I mean, my son and I found an old transmission shop here in Fort Collins, Colorado. We cleaned it out, we painted it, we mopped the floors 30 times, and turned it into our bio-production facility. Before that, I was working out of my one car garage that I quickly scaled out of after my first shipment of bottles came, and two pallets got dropped in my driveway and blocked the cars from coming in. It was really lean start-up, I think, really compelling our team. Obviously, very compelling. We’re all a driven group that wants to have a lot of fun and do great things.

Shango Los: Right on. We’re going to take another short break and be right back. You are listening to the ganjapreneur.com podcast.

Welcome back. You are listening to the Ganjapreneur.com podcast. I’m your host Shango Los, and our guest this week us Colin Bell of Growcentia. In the last segment, we were talking about specifically Growcentia’s first product, MAMMOTH P, and why it is unique, and more importantly why it caused Colin to decide to leave academia to become an entrepreneur and back it up. One of the things I really enjoyed when we were talking about bringing your product to market, Colin, was the interesting way you used lean to go out into the field and make sure your customers wanted your product before you went to the trouble of bringing the product to market.

When I was hearing that, it also made me wonder how you, as a research scientist, approached life work balance, because just like many entrepreneurs who go to market with a product that they haven’t actually market tested yet, they’re going really on passionate intuition and luck. You didn’t go that way, you wanted data, hard data, before you took your product to market. How do you handle work life balance, right? I’ve a feeling that you might have schematics drawn up to help you do that.

Colin Bell: Such a great question. It’s such an incredible challenge, especially for myself. I think for most of us in academia, we’re such a driven team and driven individuals. I think getting your PhD, going through that process, kind of weeds out the people that aren’t just kind of really obsessively driven to push, push, push. Saying that, what I realized, especially after I left the lab and left academia and started this start-up, was there’s never enough hours in the day. If you don’t take time for yourself no one else will, and that’s really unsustainable. I’ve made it a goal, and it’s really a professional goal, that we write out every year, or every quarter, if we’re not accomplishing it, to make sure not only we’re accomplishing our benchmarks and our goals professionally and internally with Growcentia, but that we have a whole list of personal goals and needs that we meet on a regular basis also.

For me personally, and my whole team, especially the co-founders, we love to ride our bikes. I personally like to run. We try to stay fit. Fort Collins is a nice environment to do that for sure. That’s what I really do, I incorporate — I’m kind of a boring guy. I work a lot and I work out a lot, and I try and have some downtime. I’m trying to balance all those things, but I need friends, I need family, I need fitness. I definitely need success in every area of my life, and that’s in all my relationships, especially with work. Ultimately, if I’m happy, I’ve succeeded. All these things in my life make me happy, and fulfill me, and so that’s what I do. I could just keep on doing that.

Shango Los: A couple shows ago, we had on Tom Burns, he’s a business philosopher who started as a yogi and is now in the cannabis business, and he says, “First, you feel good, and then you do good.” There’s a lot of that in what you just said. I also think it helps with working all the extra hours that you almost always have to do with a start-up, since fitness is one of your key things. So many entrepreneurs, they get busy, suddenly they’re not eating properly, and they’re not getting their exercise. Not only are they pushing their bodies harder with more stress and more awake time, but then they’re also not feeding the body what it needs. I would think that having a fitness regimen that you actually share with your co-workers, so you’re being supported in it, that’s probably a really great secret to success.

Colin Bell: I think so. I mean, I feel the success whenever we can do that. Actually, we have daily squat jumps and push ups and pull ups as a team in the lab, or we’ll have ten people or fifteen people in the back of the production facility, “Okay,” we’ll yell, “All right, it’s time!” We have monthly goals where we up that. We’re all jumping around, doing our squat jumps and push ups. But you know what? We all enjoy it, and it just makes us feel better, gets the blood flowing, and a sense of camaraderie and progress.

Shango Los: Oh man, this interview’s going to get you so many job inquiries it’s ridiculous, it sounds like a great place to work.

Colin Bell: Sure.

Shango Los: I want to hit one more thing. We’re almost out of time here, but one of the things that I don’t know anything about, like for example, I wasn’t too deep when you talked about your university having a tech transfer department, that’s pretty cool. That’s a new thing since I left school. What happens with the income? Since you came up with the ideas at the school in the research lab do they get a part of it, or is it they like to have the reputation of spinning off new technologies and businesses? How does that work?

Colin Bell: That’s kind of a big conversation, but in brief, and it in most universities …

Shango Los: Yeah, can you do it in 90 seconds?

Colin Bell: Yeah, yeah. Universities, if you go look at technology at the university, university actually owns that technology. As a research scientist that developed a technology that launched into the marketplace, I had to license the technology, and we did successfully, from the university. The university gets part ownership in that technology for sure. We went ahead and patented that technology so we could protect it in the marketplace, and we launched it. Colorado State University is a true partner with us in this process, being the owner of the technology. Future technology, as you launch your company and you’re in the private sector, you’re going to develop more technology which you would probably own as a company. That’s the path that most people follow whenever they actually launch a company and they’re at one point separated from the university autonomously, if you will.

Shango Los: Right on. Well, for being a really big topic you actually distilled that business model really simply, so thank you for that. That’s really interesting. That’s also all the time that we’ve got today. Colin, thank you so much for coming on the show and sharing your experience. I’m sure that you have inspired a lot of people to consider making that job.

Colin Bell: It was a pleasure, it was really fun to be here. Thank you very much for having me.

Shango Los: You can find out more about Colin Bell and MAMMOTH P at their website, mammothmicrobes.com, M-A-M-M-O-T-H-M-I-C-R-O-B-E-S.com. You can find more episodes of the Ganjapreneur Podcast in the podcast section at Ganjapreneur.com, and in the Apple iTunes Store. On the Ganjapreneur.com website, you will find the latest cannabis news, product reviews, and cannabis jobs updated daily, along with transcriptions of this podcast. You can also download the Ganjapreneur.com app in iTunes and Google Play. You can also find this show on the iHeartRadio network app, bringing Ganjapreneur to 60 million mobile devices. Do you have a company that wants to reach our national audience of cannabis enthusiasts? Email grow@ganjapreneur.com to find out how. Thanks to Brasco for producing our show. I’m your host, Shango Los.

End


New CDC Guidelines Urge Doctors to Stop Drug Testing Patients for Cannabis

The Centers for Disease Control and Prevention (CDC) have recommended via a new set of opioid-prescription guidelines that doctors stop urine testing their patients for THC, the psychoactive compound specific to cannabis.

According to the guidelines:

“Clinicians should not test for substances for which results would not affect patient management or for which implications for patient management are unclear. For example, experts noted that there might be uncertainty about the clinical implications of a positive urine drug test for tetrahyrdocannabinol (THC).”

The guidelines also urge doctors not to drop patients if they test positive for THC, which — according to the Pain News Network — is one reason that many marijuana users have been discharged from their physicians’ care.

“Clinicians should not dismiss patients from care based on a urine drug test result because this could constitute patient abandonment and could have adverse consequences for patient safety, potentially including the patient obtaining opioids from alternative sources and the clinician missing opportunities to facilitate treatment for substance use disorder.”

It’s always nice when federal establishments recognize the banality of marijuana prohibition and all of its unfortunate baggage, but it’s official changes like these that ultimately will umbrella cannabis treatment into mainstream medical practices.

Studies have shown that the rate of overdoses involving prescription drugs is significantly reduced in states with medical marijuana laws. However, with nearly 50,000 overdose victims in 2014, prescription opioids have never posed more of a threat to U.S. citizens than now.

End


Richard Branson Investigates Benefits of Colorado Cannabis Taxes

English business magnate and corporate mogul Richard Branson requested a tour of a non-disclosed substance abuse facility in Colorado last week, so that he could witness first-hand how Colorado is spending some of its cannabis-derived taxes, Ricardo Baca reports for The Cannabist.

Branson was in Colorado last week to celebrate the launch of his Virgin America airline’s services in Denver. Before leaving the land of legal marijuana, however, the self-made billionaire decided check in with some of the state’s top pot officials and industry professionals.

“There was never a blanket statement of why he was there, but we do know that Mr. Branson is interested in drug reform policy that prioritizes treatment over criminal penalties,” Robert Thompson, public information officer for the Colorado Department of Human Services, told The Cannabist.

“He wanted to learn about how things are going in Colorado with the legalization of marijuana, how things were going with collecting taxes and distributing taxes, and looking at the programs that benefit from marijuana tax dollars, including the one he toured,” Thompson said.

Branson has long been a vocal advocate for international drug policy reform, and serves on the Honorary Board for the Drug Policy Alliance.

In a blog post from 2015, he wrote that “Drugs should be treated as a health issue … so that the millions who continue to be harmed by current policies can be helped instead.”

In a 2012 op-ed for CNN, he wrote, “Rather than continuing on the disastrous path of the war on drugs, we need to look at what works and what doesn’t in terms of real evidence and data.”

End